Updated on 9 October 2026
In vitro and in vivo models with high risk pathogens
Marketing Team Leader at TAKIS SRL
rome, Italy
About
We offer the possibility to perform in vitro and in vivo studies in bsl2 and Bsl3 facilities.
Our team can also drive you in the development of new therapeutic strategies, from the design to manufacturing of vaccines and monoclonal abtibodies to be tested on infectious disease models.
Organisation
Similar opportunities
Service
Next-generation vaccines development
Laura Luberto
Marketing Team Leader at TAKIS SRL
rome, Italy
Service
- Research & Development
Gaetano Cuciniello
Discovery Services Consultant at Sygnature Discovery
Nottingham, United Kingdom
Partnership
Filippo Castiglione
Research Director at Consiglio Nazionale delle Ricerche
Rome, Italy